-The Hindu It has managed to retain stabilisation of its HIV/AIDS epidemic, holding on to prevalence rate of 0.25 % With the UNAIDS report putting India among the nations with a 50 per cent or over drop in HIV incidence rate (new infections), this is clearly good news for the country. Down south, Tamil Nadu, once considered a high-prevalence State, also has good news. The State has managed to retain stabilisation of its...
More »SEARCH RESULT
Total Matching Records found : 977
Growing crisis of drug prices
-The Hindu India’s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price...
More »Focus on spurious, substandard Drugs is more important
-The Economic Times The Union Cabinet has okayed a new price-control formula for pharmaceuticals, which seeks to cap prices at the arithmetic average of all Drugs with more than 1% market share in any therapeutic segment that is to be brought under price control. Given that the existing system of fixing prices of select Drugs is on the basis of costs, which is rigid, intrusive and prone to manipulation as well,...
More »HIV epidemic showing signs of reversal: WHO
-The Hindu With the HIV/AIDS epidemic showing signs of reversal globally, the World Health Organisation (WHO) and countries are now working towards zero new HIV infections, zero deaths from AIDS-related illnesses and zero discrimination against people living with HIV/AIDS. To achieve this goal, the WHO has emphasised the need for people to learn about their HIV status, and for greater effort to reach and support young people and men who have sex...
More »SC to Examine New Drug Pricing Policy
-Outlook The Supreme Court today said it would examine the National Pharmaceutical Pricing Policy after it is notified with the Centre promising to do it within two weeks. A bench headed by Justice G S Singhvi granted two weeks time to the Centre to issue notification and posted the matter for hearing on December 12. Additional Solicitor General Siddharth Luthra informed the court that the Cabinet had approved the policy that will bring...
More »
